A doctor shares how his patients are trying to afford weight-loss drugs - and what happens if they can't

The high prices of weight-loss drugs like semaglutide and tirzepatide make them inaccessible for many patients, leading to rationing or risky alternatives.

Patients that I speak to have tried nearly every strategy to obtain anti-obesity medications. It’s frustrating when groundbreaking treatments are out of reach.

While it's clear that semaglutide and tirzepatide represent tremendous advances in obesity management, the impact is negligible if no one can afford them.

As insurers drop coverage and prices remain astronomical, patients are forced into uncharted risks just to access potentially life-changing medications.

Read at Business Insider